Lv5
870 积分 2025-03-10 加入
Exatecan Payload-Based Antibody-Drug Conjugates with a Short Hydrophilic Cleavable Linker
10天前
已完结
Tumor Microenvironment-Responsive Antibody Fragment-Cleavable PEGylated Drug Conjugates (AFCDC) for Improved Tumor Penetration and Antitumor Efficacy
10天前
已完结
Design of Novel Exatecan-Amide Linker-Payloads for the Development of Stable, Low-Aggregating, and Highly Efficacious Antibody-Drug Conjugates
10天前
已完结
Discovery of Novel N-Linked Camptothecin Linker-Payloads to Access Antibody-Drug Conjugates with High Target-Mediated In Vivo Efficacy
12天前
已完结
Approved Steroidal Drugs (2000–2025): A Medicinal Chemistry Perspective
21天前
已完结
Advances and challenges in immunosuppressive antibody drug conjugates
21天前
已完结
Development of Novel Glucocorticoids for Use in Antibody–Drug Conjugates for the Treatment of Inflammatory Diseases
23天前
已完结
Self-Immolative Carbamate Linkers for CD19-Budesonide Antibody–Drug Conjugates
23天前
已完结
Rethinking ADC Design: Lessons from NBE-002 and the Potency of PNU-159682
24天前
已关闭
Utilization of Neutrophil Elastase Tetrapeptide Substrate as a Linker Agent for Anti-GD2 Antibody Drug Conjugates
27天前
已完结
皖公网安备34019202002308
